CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2020 Financial ResultsGlobeNewsWire • 02/16/21
CRISPR Therapeutics to Participate in the Guggenheim Healthcare Talks 2021 Oncology DayGlobeNewsWire • 02/05/21
CRISPR Therapeutics Announces the Appointment of Philippe Drouet as Chief Commercial OfficerGlobeNewsWire • 02/01/21